ImmuPharma CEO confident on P140 partnership as strong pharma interest extends timeline into 2026
28 November 2025
ImmuPharma PLC (AIM:IMM) CEO Tim McCarthy talked with Proactive’s Stephen Gunnion about the company’s ongoing discussions to secure a partnership for its lead asset, P140 – November 2025